When Should We Start Sodium–Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention-Reference-Cited by-同舟云学术

When Should We Start Sodium–Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention

Published:2023-06-07 Issue: Volume:18 Page:
ISSN:1758-3764
Container-title:European Cardiology Review
language:en
Short-container-title:Eur Cardiol

Author:

Iguchi Moritake¹^ORCID,Wada Hiromichi²^ORCID,Martínez Felipe³^ORCID,Hasegawa Koji²^ORCID

Affiliation:

1. Department of Cardiac Rehabilitation, National Hospital Organization Kyoto Medical Center, Kyoto, Japan

2. Division of Translational Research, National Hospital Organization Kyoto Medical Center, Kyoto, Japan

3. Córdoba National University, Córdoba, Argentina

Publisher

Radcliffe Media Media Ltd

Subject

Cardiology and Cardiovascular Medicine

Reference13 articles.

1. McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 2019;381:1995–2008. https://doi.org/10.1056/NEJMoa1911303; PMID: 31535829.

2. Packer M, Anker SD, Butler J, et al. Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med 2020;383:1413–24. https://doi.org/10.1056/NEJMoa2022190; PMID: 32865377.

3. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599–726. https://doi.org/10.1093/eurheartj/ehab368; PMID: 34447992.

4. Anker SD, Butler J, Filippatos G, et al. Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med 2021;385:1451–61. https://doi.org/10.1056/NEJMoa2107038; PMID: 34449189.

5. Solomon SD, McMurray JJV, Claggett B, et al. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med 2022;387:1089–98. https://doi.org/10.1056/NEJMoa2206286; PMID: 36027570.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies for the Management of Cardiorenal Syndrome in the Acute Hospital Setting;Hearts;2024-08-01

2. Progress of patients hospitalized with acute heart failure treated with empagliflozin;Journal of Comparative Effectiveness Research;2024-06